Chemoinformaics analysis of (3E)-HEXADECA-1,3-DIEN-5-YNE
| Molecular Weight | 218.384 | nRot | 9 |
| Heavy Atom Molecular Weight | 192.176 | nRig | 17 |
| Exact Molecular Weight | 218.203 | nRing | 0 |
| Solubility: LogS | -3.393 | nHRing | 0 |
| Solubility: LogP | 4.059 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 44.0566 |
| nHD | 0 | BPOL | 26.0834 |
| QED | 0.278 |
| Synth | 3.642 |
| Natural Product Likeliness | 1.607 |
| NR-PPAR-gamma | 0.969 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.009 |
| HIA | 0.006 |
| CACO-2 | -4.793 |
| MDCK | 0.0000188 |
| BBB | 0.043 |
| PPB | 0.998038 |
| VDSS | 0.578 |
| FU | 0.00639352 |
| CYP1A2-inh | 0.964 |
| CYP1A2-sub | 0.407 |
| CYP2c19-inh | 0.786 |
| CYP2c19-sub | 0.057 |
| CYP2c9-inh | 0.894 |
| CYP2c9-sub | 0.917 |
| CYP2d6-inh | 0.564 |
| CYP2d6-sub | 0.367 |
| CYP3a4-inh | 0.816 |
| CYP3a4-sub | 0.18 |
| CL | 5.868 |
| T12 | 0.552 |
| hERG | 0.375 |
| Ames | 0.893 |
| ROA | 0.609 |
| SkinSen | 0.947 |
| Carcinogencity | 0.506 |
| EI | 0.099 |
| Respiratory | 0.276 |
| NR-Aromatase | 0.906 |
| Antiviral | Yes |
| Prediction | 0.764407 |